Table of Contents:
  • Overview
  • Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer
  • Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf, and MEK
  • Farnesyl Protein Transferase Inhibitors: Medicinal Chemistry, Molecular Mechanisms, and Progress in the Clinic
  • Survival Signaling
  • Progress in the Development of Agents to Control the Cell Cycle
  • HDAC Inhibition in Cancer Therapy: An Increasingly Intriguing Tale of Chemistry, Biology and Clinical Benefit
  • Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy
  • Novel Small-Molecule Inhibitors of Src Kinase for Cancer Therapy
  • Bcr-Abl Kinase Inhibitors.